SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014410
Filing Date
2023-08-10
Accepted
2023-08-10 08:01:45
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ewtx-20230630x10q.htm   iXBRL 10-Q 1893645
2 EX-31.1 ewtx-20230630xex31d1.htm EX-31.1 19403
3 EX-31.2 ewtx-20230630xex31d2.htm EX-31.2 19216
4 EX-32.2 ewtx-20230630xex32d2.htm EX-32.2 7610
5 EX-32.1 ewtx-20230630xex32d1.htm EX-32.1 7533
  Complete submission text file 0001558370-23-014410.txt   5892275

Data Files

Seq Description Document Type Size
6 EX-101.SCH ewtx-20230630.xsd EX-101.SCH 31590
7 EX-101.CAL ewtx-20230630_cal.xml EX-101.CAL 36236
8 EX-101.DEF ewtx-20230630_def.xml EX-101.DEF 122877
9 EX-101.LAB ewtx-20230630_lab.xml EX-101.LAB 324150
10 EX-101.PRE ewtx-20230630_pre.xml EX-101.PRE 228302
46 EXTRACTED XBRL INSTANCE DOCUMENT ewtx-20230630x10q_htm.xml XML 880492
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 231157250
SIC: 2834 Pharmaceutical Preparations